Characterization of a rabbit anti‐human malignant glioma antiserum
- 15 September 1981
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 28 (3) , 267-273
- https://doi.org/10.1002/ijc.2910280303
Abstract
An antiglioma antiserum was produced by immunization of a rabbit with membrane‐enriched preparations of a human malignant glioma cell line, LN‐18. After extensive absorption, this antiserum reacted exclusively with antigenic determinants present on seven out of 16 malignant glioma cell lines tested, as shown by complement‐dependent cytotoxicity in a 51Cr‐release assay. This glioma specificity could be further confirmed by quantitative absorption experiments where cells from a glioma line, LN‐135, abolished the cytolytic reactivity of the antiserum against four other glioma lines. The step‐wise absorption of the crude antiserum consisted of: step 1, absorption with normal peripheral blood lymphocytes from 10 individual donors; step 2, absorption with a pool of cells from four different lymphoblastoid cell lines and one endometrial carcinoma; step 3, absorption with cells from a colon carcinoma; and step 4, absorption with cells from two different melanoma lines. After each absorption step the antiserum was tested by complement‐dependent cytotoxicity against a large panel of malignant glioma lines and control non‐glioma cell lines. After the absorptions from step 1 and 2 the antiserum reacted with all cell lines tested, while after step 3 absorption, it reacted only with cells from malignant glioma, melanomas and fetal brain. Quantitative absorption experiments performed at this stage with fetal brain cells showed that the reactivity for fetal brain and melanoma cells could be abolished, while the antiserum was still cytolytic for malignant gliomas. After the absorption from step 4, the antiserum reacted exclusively with seven malignant gliomas. After a further absorption with normal adult brain homogenate, the antiserum still reacted with four of the seven malignant glioma cell lines. Thus, the antiserum described here recognized three types of antigens: antigens common to cells of neuroectodermal origin, antigens shared by malignant gliomas and adult brain, and antigens expressed only on some gliomas.This publication has 29 references indexed in Scilit:
- Changes of serum thymic factor levels in friend leukemia virus-infected miceLeukemia Research, 1979
- In vitro induction of cell-mediated immunity to murine leukemia cells. I. Optimization of tissue culture conditions for the generation of cytotoxic lymphocytesJournal of Immunological Methods, 1976
- Mechanisms of genetic resistance to Friend virus leukemia in mice. II. Resistance of mitogen-responsive lymphocytes mediated by marrow-dependent cells.The Journal of Experimental Medicine, 1976
- Immunosuppressive activity of a subline of the mouse EL-4 lymphoma. Evidence for minute virus of mice causing the inhibition.The Journal of Experimental Medicine, 1976
- Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificityInternational Journal of Cancer, 1975
- „Natural”︁ killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotypeEuropean Journal of Immunology, 1975
- Brief Communication: Friend Leukemia: Rapid Development of Erythropoietin-Independent Hematopoietic Precursors2JNCI Journal of the National Cancer Institute, 1975
- EVIDENCE OF SUPPRESSOR CELL ACTIVITY IN SPLEENS OF MICE BEARING PRIMARY TUMORS INDUCED BY MOLONEY SARCOMA VIRUSThe Journal of Experimental Medicine, 1974
- Cell-Mediated Cytotoxicity, Allograft Rejection, and Tumor ImmunityPublished by Elsevier ,1974
- CELL-FREE TRANSMISSION IN ADULT SWISS MICE OF A DISEASE HAVING THE CHARACTER OF A LEUKEMIAThe Journal of Experimental Medicine, 1957